Literature DB >> 15381106

Transglutaminase 2 induces nitric oxide synthesis in BV-2 microglia.

Key Chung Park1, Kyung Cheon Chung, Yoon-Seong Kim, Jongmin Lee, Tong H Joh, Soo-Youl Kim.   

Abstract

A hallmark of brain inflammation is the activation of microglia. Excessive production of nitric oxide (NO), as a consequence of increased inducible nitric oxide synthase (iNOS) in glia, contributes to neurodegeneration. Transglutaminase 2 (TGase 2) is a cross-linking enzyme, which is increased in neurodegeneration. TGase 2 is also considered to be a useful and reliable marker for activation levels in resident and inflammatory macrophages. Therefore, an increase of TGase 2 expression may contribute to activation of microglia. To test this hypothesis, we analyzed the expression of TGase 2 in BV-2 microglia activated with lipopolysaccharide (LPS). Total TGase activity was increased about 5-fold after 24h exposure to LPS. The increase of NO synthesis is correlated with increase of TGase 2 expression. Secretion of NO was reduced between 40 and 80% by TGase inhibition in a dose-dependent manner. This suggests that TGase 2 appears to control iNOS transcription.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15381106     DOI: 10.1016/j.bbrc.2004.08.204

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Characterization of transglutaminase type II role in dendritic cell differentiation and function.

Authors:  Ivana Matic; Alessandra Sacchi; Alessandra Rinaldi; Gennaro Melino; Chaitan Khosla; Laura Falasca; Mauro Piacentini
Journal:  J Leukoc Biol       Date:  2010-04-06       Impact factor: 4.962

2.  Gng12 is a novel negative regulator of LPS-induced inflammation in the microglial cell line BV-2.

Authors:  Kelley C Larson; Maciej Lipko; Michal Dabrowski; Michael P Draper
Journal:  Inflamm Res       Date:  2009-07-01       Impact factor: 4.575

3.  Anti-inflammatory effects of the R2 peptide, an inhibitor of transglutaminase 2, in a mouse model of allergic asthma, induced by ovalbumin.

Authors:  Dae Yong Kim; Bum Soo Park; Gwan Ui Hong; Byung Jae Lee; Jung Won Park; Soo Youl Kim; Jai Youl Ro
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

4.  A novel therapeutic target in inflammatory uveitis: transglutaminase 2 inhibitor.

Authors:  Joonhong Sohn; Ju Byung Chae; Sun Young Lee; Soo-Youl Kim; June-Gone Kim
Journal:  Korean J Ophthalmol       Date:  2010-02-05

Review 5.  Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases.

Authors:  Gary E Gibson; Anatoly Starkov; John P Blass; Rajiv R Ratan; M Flint Beal
Journal:  Biochim Biophys Acta       Date:  2009-08-26

Review 6.  Transglutaminases and neurodegeneration.

Authors:  Thomas M Jeitner; John T Pinto; Boris F Krasnikov; Mark Horswill; Arthur J L Cooper
Journal:  J Neurochem       Date:  2009-05       Impact factor: 5.372

7.  Transglutaminase activation in neurodegenerative diseases.

Authors:  Thomas M Jeitner; Nancy A Muma; Kevin P Battaile; Arthur Jl Cooper
Journal:  Future Neurol       Date:  2009-07-01

8.  Significant association of estrogen receptor binding site variation with bipolar disorder in females.

Authors:  Lisette Graae; Robert Karlsson; Silvia Paddock
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

9.  Tissue transglutaminase in marmoset experimental multiple sclerosis: discrepancy between white and grey matter.

Authors:  Nathaly Espitia Pinzon; Esther Stroo; Bert A 't Hart; John G J M Bol; Benjamin Drukarch; Jan Bauer; Anne-Marie van Dam
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

10.  Purple sweet potato color ameliorates cognition deficits and attenuates oxidative damage and inflammation in aging mouse brain induced by d-galactose.

Authors:  Qun Shan; Jun Lu; Yuanlin Zheng; Jing Li; Zhong Zhou; Bin Hu; Zifeng Zhang; Shaohua Fan; Zhen Mao; Yong-Jian Wang; Daifu Ma
Journal:  J Biomed Biotechnol       Date:  2009-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.